Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American States Water Company (AWR) vs GeneDx Holdings Corp (WGS) Price & Performance

American States Water CompanyTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

American States Water Company vs GeneDx Holdings Corp — how do they compare? American States Water Company trades at $87.85 (market cap $3.47B), while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: American States Water Company is the larger of the two by market cap, and American States Water Company pays a 2.49% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

AWRWGS
Market Cap
$3.47B$2.44B
Sector
UtilitiesTechnology
52-Week High
$89.28$167.51
52-Week Low
$70.10$34.51
Enterprise Value
$4.37B$2.48B
Dividend Yield
2.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American States Water Company

AWR trades at $87.95, up 1.59% on the day, with a bullish technical signal from moving averages. The company reported a Q2 2026 EPS beat of $1.09 versus $0.915 expected, driven by water rate increases and revenue growth. Recent news highlights its 71-year dividend growth streak and an 8.2% dividend hike announced in July 2026. Financials show solid profitability with a 20.52% net income margin and ROE of 13.62%, though valuation ratios like P/E of 23.92 are above sector averages.

Outlook is mixed: strong dividend history and earnings growth support income investors, but elevated valuation and mixed analyst consensus (20% buy, 50% hold, 30% sell) suggest limited near-term upside. Key risks include regulatory dependence on rate approvals and potential overvaluation relative to peers.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.

Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American States Water Company

American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.

Read more on AWR

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS